AZ And Boehringer Move Into Phase III With Rival Next-Gen CKD Drugs

 
• By Andrew McConaghie
  
Kidney
Chronic kidney disease is estimated to affect around 850 million people worldwide • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D